📰 Tech & Money Press: markets, crypto & tech news for traders. Fast, clear, no fluff.
Every trading day:
👀 Stocks to Watch + key levels
📋 How the picks played out
📈 Market & crypto analysis
Read more 👇
https://t.co/uoxUotN5Cc
How did our Nov. 11 stocks to watch trade? 📊 4 of 5 closed higher
📈 $GEVO +30.9% on 30M+ shares, never went below its first 15-minute low
📈 $PEPG +14.1% even after a $125M stock offering
📈 $TTEC +11.3%, spiked to $3.03, then faded
📈 $KULR +3.0% on light volume
📉 $SATL −2.6%, its pre-market gap faded all day
🌐 Nasdaq +1.6% as CoreWeave lifted chip stocks (Kiplinger)
Which of these five stories caught your attention? 👇
#stockmarketnews #watchlist #stocknews #stocks #investingeducation
For news and education only. Not financial advice.
Nov 11 watchlist recap 📊 4 of 5 closed higher
$GEVO +30.9% on 30M shares
$PEPG +14.1%
$TTEC +11.3%
$KULR +3.0%
$SATL −2.6%, gap faded
What stood out to you?
#StockMarket#Recap $GEVO $PEPG $TTEC $KULR $SATL
For news and education only. Not financial advice. https://t.co/vVXuJ8pCjN
5 stocks in the news for Thursday 📰 Earnings, a guidance cut and an FDA date
📈 $AVEX +12% after hours: Q3 revenue +56%, outlook raised (company report)
📈 $CURI +16% after hours: back to a profit on AI licensing deals
📉 $OPRX −20% after hours: 2026 revenue outlook lowered
🧬 $CAPR +26%: FDA decision on its Duchenne therapy due Nov. 22
🥫 $BGS +38% on 5x Tuesday's volume after an earnings beat
📊 Key levels for each one are on the charts. Full list on https://t.co/MbIxJHtRBa
Which catalyst stands out most to you: earnings, guidance or the FDA date? 👇
#stockstowatch #stockmarketnews #earnings #premarket #investingeducation
For news and education only. Not financial advice.
5 stocks in the news for Thu Nov 12 📰
$AVEX +12% AH, Q3 beat
$CURI +16% AH, AI licensing
$OPRX −20% AH, guidance cut
$CAPR +26%, FDA date Nov 22
$BGS +38% on 5x volume
Which catalyst stands out?
#StocksToWatch $AVEX $CURI $OPRX $CAPR $BGS
For news and education only. Not financial advice. https://t.co/0D538Tnzj1
⚡ $TLN +5.5% on a 7-year, 750 MW capacity deal worth ~$100M a year
📊 40% of gross margin now contracted through 2036
Our Take: some upside traded for certainty. Worth it 👇
https://t.co/doCvvUJ5I0
#TalenEnergy#AIstocks $TLN
🚨 $NVDA +3.8% after a 9.5% two-day drop, but the board's Huang probe is still open.
🧾 Earnings Nov. 17
🎯 $185.22 / $163.90
Our Take: a relief bounce, not an all-clear 👇
https://t.co/0oTcOaIxjX
#Nvidia#AIstocks
Nvidia is green again, but is the Huang problem really over? 👀
📉 −9.5% in two days after the board opened a probe into CEO Jensen Huang
📈 Back near $175.30 today (+3.8%, Webull, 11:14 a.m. ET)
🧾 Earnings Nov. 17, guide: $108B ±2%
🎯 Levels: $185.22 to fill the gap, $163.90 is the 52-week low
💡 Our Take: a relief bounce, not an all-clear.
Would you buy NVDA before earnings or wait? 👇
🔗 Full breakdown: link in bio
Not financial advice.
#Nvidia #NVDA #StockMarket #AIStocks #Investing
🤯 Anthropic hasn't priced its IPO yet and bankers are already talking $1.5T+ (per the FT)
💰 $70–78/share, 825M shares
🏷️ Ticker: ANT
📊 ~$1.404T fully diluted at the top
🚀 Q3 revenue ~$17B vs. ~$1.4B a year ago
Bubble or bargain? 👇
https://t.co/z0u9W2YFyN
#Anthropic#IPO
Anthropic hasn't even priced its IPO, and bankers are already weighing a $1.5 TRILLION valuation (per the FT). 🤯
Range: $70–78/share, 825M shares, ticker ANT
Top of range: ~$1.404T fully diluted
Q3 revenue: $17B (vs. $1.4B a year ago)
Expected pricing Nov. 18, trading Nov. 19 on Nasdaq
Our take: the demand is real, and so is the price tag. The final price will be the best read on AI sentiment this month.
Follow @techmoneypress for daily market news + our take.
Not financial advice.
#Anthropic #IPO #AI #Claude #stockmarket #investing #AIstocks #techstocks #Nasdaq #stocks #ourtake #TechAndMoneyPress
CoreWeave just beat, and the stock is up about 14% premarket. 🚀 But read the fine print.
Q3 revenue: $3.66B (+168% YoY) vs. $3.55B expected
2026 guidance raised to $13.0–13.3B
Backlog: $132.5B
But net interest expense was $846M, about 4x operating income ($207M) ����
Our take: demand isn't the question. Funding is. We're watching $57.80 to confirm the move and $47.06 if it fails.
Full Our Take at https://t.co/MbIxJHtjLC (link in bio)
Not financial advice.
#CoreWeave #CRWV #earnings #AIstocks #stockmarket #investing #Nvidia #AI #neocloud #stocks #techstocks #ourtake #TechAndMoneyPress
Hot CPI just put a bigger Fed hike back on the table 🔥📈
Core CPI rose 0.3% vs 0.2% expected. Waller said that's the line for a half-point hike, and it was met. The 2-year yield jumped 17 bps, while SPY only fell 0.4%.
Our Take: stocks held up, but bonds sent the louder warning. Watch $752.69 above and $747.74 below.
Full breakdown on https://t.co/MbIxJHtjLC (link in bio)
Not financial advice.
#CPI #inflation #FederalReserve #Fed #stockmarket #SPY #investing #trading #finance #fintok #stocks #economy #interestrates #wallstreet #marketnews
Hot October CPI: +0.4% headline, core 0.3%. That clears Waller's bar, so a bigger December Fed hike is back on the table.
Our Take on yields, stocks and the SPY levels to watch 👇
https://t.co/lBr3s1a1Ux
#CPI#Fed#Inflation#SPY#StockMarket
🚨 5 stocks to watch Wednesday 👀 $TTEC ran 72% 🚀 $PEPG nearly doubled, then dropped a $125M offering 😳 Key levels inside 📊 Which one are you watching? 👇
🔗 Link in bio 👉 look for "WATCHLIST"
⚠️ Not financial advice
#stockstowatch#daytrading#stocks#stockmarket #pennystocks #trading #investing #fintok #stocktok #premarket #fyp
📊 2 HITS. 2 MISSES. The honest scorecard 👀 $TTEC ran 72% 🚀 $BW stopped 1 CENT under our level 🎯 and two of our picks failed ❌ Did you catch TTEC? 👇
🔗 Link in bio 👉 look for "WATCHLIST RECAP"
⚠️ Not financial advice
#watchlistrecap#daytrading#stocks#stockmarket #pennystocks #trading #investing #fintok #stocktok #TTEC #fyp